Patent ID: 7863414

Claim:
A method of treating cardiac hypertrophy, heart failure, dilated cardiomyopathy, or arrhythmias comprising: (a) identifying a subject suffering from or at risk of developing cardiac hypertrophy, heart failure, dilated cardiomyopathy, or arrhythmias; and (b) administering to said patient an Histone Deacetylase (HDAC) 4 peptide of 5 to 25 consecutive residues of HDAC4 and comprising the docking site to Calcium/Calmodulin Kinase II (CaMKII), or a CaMKII peptide of 5 to 25 consecutive residues of CaMKII and comprising the docking site to HDAC4, that inhibits the interaction between HDAC4 and CaMKII.